Saturday, July 15

• Phil's Journal: Before AAIC in Amsterdam, Leading Alzheimer's Advocates Weigh in | BeingPatient
• With Momentum on Alzheimer’s Therapies, Europe Sees Delivery Challenges Ahead, Too | STAT

Sunday, July 16

• Researchers Turn to CRISPR to Unlock One of the Trickiest Diseases to Treat: Alzheimer’s | STAT
• Scientists Turn CRISPR Scissors to Genes Involved in Alzheimer’s | Fierce Biotech
• With New Therapies That Promise to Slow Alzheimer’s Disease, Researchers Race to Reform How Patients are Diagnosed | CNN
• Acumen's Alzheimer's Drug Passes Initial Safety Test | Reuters
• New Dementia Drugs: Patients to Pay Privately or Face NHS Postcode Lotter | The Guardian

Monday, July 17

• Alzheimer's Diagnosis Revamp Embraces Rating Scale Similar to Cancer | Reuters
• Eli Lilly’s Experimental Alzheimer’s Drug Slows Disease, Data Show | The Washington Post
• Gene-Editing Tools Pave Way for New Alzheimer's Treatments | Health Day
• In These 10 U.S. Counties, 1 in 6 People Over 65 Have Alzheimer’s Disease | Being Patient
• Alzheimer’s Disease Most Common Among Seniors in the East and Southeast Regions of the US, New Study Suggests | CNN
• Eli Lilly Drug Shown to Slow Alzheimer’s Progression | Financial Times

Tuesday, July 18

• Eli Lilly Expects FDA Decision on Alzheimer’s Treatment Donanemab by the End of the Year | CNBC
• An Experimental Alzheimer's Drug Outperforms One Just Approved by the FDA | NPR
• Eli Lilly's Donanemab Slows Early Stages of Alzheimer's Disease, Study Shows | USA Today
• Experts Urge Health Regulators to Approve ‘Turning Point’ Dementia Drugs | Alzheimer's | The Guardian
• Alzheimer's Disease is More Prevalent in These Parts of the US | Scripps News
• Experimental Drug Slows Alzheimer's Decline in Early-Stage Patients | Axios
• Opioid Use in People with Dementia Linked with 11 Times Higher Risk of Death Within Two Weeks, New Research Shows | Market Watch
• New Opioid Use Raises Death Risk 11-Fold in Those With Dementia | HealthDay

Wednesday, July 19

• Here’s Where the Highest Rates of Alzheimer’s Are in the United States | Smithsonian Magazine
• Study: Taking Opioids After Dementia Diagnosis Raises Mortality Risk | McKnight’s Long-Term Care News
• Study Shows Promising Results for Potential Alzheimer’s Treatment | AARP
• An Experimental Alzheimer's Drug Has Been Shown to Slow the Disease in a New Study | NPR Morning Edition
• Hearing Aids May Slow Mental Decline in Those at Higher Risk of Dementia, Study Finds | STAT
• Draft Revision of Alzheimer’s Diagnostic Criteria Includes Blood-Based Biomarkers | Healio
• Pooping Only Every 3 or More Days Linked with Cognitive Decline, Research Finds | CNN
• How Constipation May Be Linked to Cognitive Decline, and Other Ways Gut Health is Linked to Brain Health | NBC News
• At-Home Alzheimer’s Testing is on the Horizon, Researchers Say | MarketWatch

Thursday, July 20

• Being Constipated Could Point to Cognitive Decline | McKnight’s Long-Term Care News
• Constipation Linked to Cognitive Decline, Research Finds | People
• Being Constipated Could Point to Cognitive Decline | The New York Times
• Hearing Aids May Cut Risk of Cognitive Decline by Nearly Half | Washington Post
• Simple Test Offers Major Breakthrough in Alzheimer’s Detection | Metro